Global RNA Drugs Market Insights, Forecast to 2028

Published: April 2022

No. of Pages: 117

Price:

Single User License: US $ 4900

Corporate User License: US $ 9800

Report Description
Table of Contents

RNA Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global RNA Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
- siRNA
- ASO
- miRNA
- Nucleic Acid Aptamers

Segment by Application
- Cancer
- Diabetes
- Tuberculosis
- Cardiovascular Diseases
- Others

By Company
- Pfizer
- Roche
- Sanofi-Aventis
- Abbott Laboratories
- Arrowhead Pharmaceuticals
- Benitec Biopharma
- Calimmune Inc
- Dicerna
- Gradalis
- Quark
- RXi
- Senesco
- Silence Therapeutics
- Silenseed
- Tekmira
- Alnylam Pharmaceuticals

By Region
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E

Table of Contents

1 Study Coverage
1.1 RNA Drugs Product Introduction
1.2 Market by Type
1.2.1 Global RNA Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 Market by Application
1.3.1 Global RNA Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global RNA Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global RNA Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global RNA Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global RNA Drugs Sales by Region
2.4.1 Global RNA Drugs Sales by Region (2017-2022)
2.4.2 Global Sales RNA Drugs by Region (2023-2028)
2.5 Global RNA Drugs Revenue by Region
2.5.1 Global RNA Drugs Revenue by Region (2017-2022)
2.5.2 Global RNA Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global RNA Drugs Sales by Manufacturers
3.1.1 Global Top RNA Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global RNA Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of RNA Drugs in 2021
3.2 Global RNA Drugs Revenue by Manufacturers
3.2.1 Global RNA Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global RNA Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by RNA Drugs Revenue in 2021
3.3 Global RNA Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global RNA Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global RNA Drugs Sales by Type
4.1.1 Global RNA Drugs Historical Sales by Type (2017-2022)
4.1.2 Global RNA Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global RNA Drugs Sales Market Share by Type (2017-2028)
4.2 Global RNA Drugs Revenue by Type
4.2.1 Global RNA Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global RNA Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global RNA Drugs Revenue Market Share by Type (2017-2028)
4.3 Global RNA Drugs Price by Type
4.3.1 Global RNA Drugs Price by Type (2017-2022)
4.3.2 Global RNA Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global RNA Drugs Sales by Application
5.1.1 Global RNA Drugs Historical Sales by Application (2017-2022)
5.1.2 Global RNA Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global RNA Drugs Sales Market Share by Application (2017-2028)
5.2 Global RNA Drugs Revenue by Application
5.2.1 Global RNA Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global RNA Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global RNA Drugs Revenue Market Share by Application (2017-2028)
5.3 Global RNA Drugs Price by Application
5.3.1 Global RNA Drugs Price by Application (2017-2022)
5.3.2 Global RNA Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America RNA Drugs Market Size by Type
6.1.1 North America RNA Drugs Sales by Type (2017-2028)
6.1.2 North America RNA Drugs Revenue by Type (2017-2028)
6.2 North America RNA Drugs Market Size by Application
6.2.1 North America RNA Drugs Sales by Application (2017-2028)
6.2.2 North America RNA Drugs Revenue by Application (2017-2028)
6.3 North America RNA Drugs Market Size by Country
6.3.1 North America RNA Drugs Sales by Country (2017-2028)
6.3.2 North America RNA Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe RNA Drugs Market Size by Type
7.1.1 Europe RNA Drugs Sales by Type (2017-2028)
7.1.2 Europe RNA Drugs Revenue by Type (2017-2028)
7.2 Europe RNA Drugs Market Size by Application
7.2.1 Europe RNA Drugs Sales by Application (2017-2028)
7.2.2 Europe RNA Drugs Revenue by Application (2017-2028)
7.3 Europe RNA Drugs Market Size by Country
7.3.1 Europe RNA Drugs Sales by Country (2017-2028)
7.3.2 Europe RNA Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific RNA Drugs Market Size by Type
8.1.1 Asia Pacific RNA Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific RNA Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific RNA Drugs Market Size by Application
8.2.1 Asia Pacific RNA Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific RNA Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific RNA Drugs Market Size by Region
8.3.1 Asia Pacific RNA Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific RNA Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America RNA Drugs Market Size by Type
9.1.1 Latin America RNA Drugs Sales by Type (2017-2028)
9.1.2 Latin America RNA Drugs Revenue by Type (2017-2028)
9.2 Latin America RNA Drugs Market Size by Application
9.2.1 Latin America RNA Drugs Sales by Application (2017-2028)
9.2.2 Latin America RNA Drugs Revenue by Application (2017-2028)
9.3 Latin America RNA Drugs Market Size by Country
9.3.1 Latin America RNA Drugs Sales by Country (2017-2028)
9.3.2 Latin America RNA Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa RNA Drugs Market Size by Type
10.1.1 Middle East and Africa RNA Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa RNA Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa RNA Drugs Market Size by Application
10.2.1 Middle East and Africa RNA Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa RNA Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa RNA Drugs Market Size by Country
10.3.1 Middle East and Africa RNA Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa RNA Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Overview
11.2.3 Roche RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Roche RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Corporation Information
11.3.2 Sanofi-Aventis Overview
11.3.3 Sanofi-Aventis RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi-Aventis RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi-Aventis Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Corporation Information
11.4.2 Abbott Laboratories Overview
11.4.3 Abbott Laboratories RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Abbott Laboratories RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Laboratories Recent Developments
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Corporation Information
11.5.2 Arrowhead Pharmaceuticals Overview
11.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Arrowhead Pharmaceuticals RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Arrowhead Pharmaceuticals Recent Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Corporation Information
11.6.2 Benitec Biopharma Overview
11.6.3 Benitec Biopharma RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Benitec Biopharma RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Benitec Biopharma Recent Developments
11.7 Calimmune Inc
11.7.1 Calimmune Inc Corporation Information
11.7.2 Calimmune Inc Overview
11.7.3 Calimmune Inc RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Calimmune Inc RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Calimmune Inc Recent Developments
11.8 Dicerna
11.8.1 Dicerna Corporation Information
11.8.2 Dicerna Overview
11.8.3 Dicerna RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Dicerna RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dicerna Recent Developments
11.9 Gradalis
11.9.1 Gradalis Corporation Information
11.9.2 Gradalis Overview
11.9.3 Gradalis RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Gradalis RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Gradalis Recent Developments
11.10 Quark
11.10.1 Quark Corporation Information
11.10.2 Quark Overview
11.10.3 Quark RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Quark RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Quark Recent Developments
11.11 RXi
11.11.1 RXi Corporation Information
11.11.2 RXi Overview
11.11.3 RXi RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 RXi RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 RXi Recent Developments
11.12 Senesco
11.12.1 Senesco Corporation Information
11.12.2 Senesco Overview
11.12.3 Senesco RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Senesco RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Senesco Recent Developments
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Corporation Information
11.13.2 Silence Therapeutics Overview
11.13.3 Silence Therapeutics RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Silence Therapeutics RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Silence Therapeutics Recent Developments
11.14 Silenseed
11.14.1 Silenseed Corporation Information
11.14.2 Silenseed Overview
11.14.3 Silenseed RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Silenseed RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Silenseed Recent Developments
11.15 Tekmira
11.15.1 Tekmira Corporation Information
11.15.2 Tekmira Overview
11.15.3 Tekmira RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Tekmira RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Tekmira Recent Developments
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Corporation Information
11.16.2 Alnylam Pharmaceuticals Overview
11.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Alnylam Pharmaceuticals RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Alnylam Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 RNA Drugs Industry Chain Analysis
12.2 RNA Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 RNA Drugs Production Mode & Process
12.4 RNA Drugs Sales and Marketing
12.4.1 RNA Drugs Sales Channels
12.4.2 RNA Drugs Distributors
12.5 RNA Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 RNA Drugs Industry Trends
13.2 RNA Drugs Market Drivers
13.3 RNA Drugs Market Challenges
13.4 RNA Drugs Market Restraints
14 Key Findings in The Global RNA Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global RNA Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of siRNA
Table 3. Major Manufacturers of ASO
Table 4. Major Manufacturers of miRNA
Table 5. Major Manufacturers of Nucleic Acid Aptamers
Table 6. Global RNA Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global RNA Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global RNA Drugs Sales by Region (2017-2022) & (K Units)
Table 9. Global RNA Drugs Sales Market Share by Region (2017-2022)
Table 10. Global RNA Drugs Sales by Region (2023-2028) & (K Units)
Table 11. Global RNA Drugs Sales Market Share by Region (2023-2028)
Table 12. Global RNA Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global RNA Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global RNA Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global RNA Drugs Revenue Market Share by Region (2023-2028)
Table 16. Global RNA Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global RNA Drugs Sales Share by Manufacturers (2017-2022)
Table 18. Global RNA Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global RNA Drugs Revenue Share by Manufacturers (2017-2022)
Table 20. RNA Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global RNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global RNA Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Drugs as of 2021)
Table 23. RNA Drugs Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers RNA Drugs Product Offered
Table 25. Date of Manufacturers Enter into RNA Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 28. Global RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 29. Global RNA Drugs Sales Share by Type (2017-2022)
Table 30. Global RNA Drugs Sales Share by Type (2023-2028)
Table 31. Global RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global RNA Drugs Revenue Share by Type (2017-2022)
Table 34. Global RNA Drugs Revenue Share by Type (2023-2028)
Table 35. RNA Drugs Price by Type (2017-2022) & (USD/Unit)
Table 36. Global RNA Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 38. Global RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 39. Global RNA Drugs Sales Share by Application (2017-2022)
Table 40. Global RNA Drugs Sales Share by Application (2023-2028)
Table 41. Global RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global RNA Drugs Revenue Share by Application (2017-2022)
Table 44. Global RNA Drugs Revenue Share by Application (2023-2028)
Table 45. RNA Drugs Price by Application (2017-2022) & (USD/Unit)
Table 46. Global RNA Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 48. North America RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 49. North America RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 52. North America RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 53. North America RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 56. North America RNA Drugs Sales by Country (2023-2028) & (K Units)
Table 57. North America RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America RNA Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 60. Europe RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 61. Europe RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Europe RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 65. Europe RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 68. Europe RNA Drugs Sales by Country (2023-2028) & (K Units)
Table 69. Europe RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe RNA Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific RNA Drugs Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific RNA Drugs Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific RNA Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific RNA Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 84. Latin America RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 85. Latin America RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 88. Latin America RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 89. Latin America RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 92. Latin America RNA Drugs Sales by Country (2023-2028) & (K Units)
Table 93. Latin America RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America RNA Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa RNA Drugs Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa RNA Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Pfizer RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Roche Corporation Information
Table 113. Roche Description and Major Businesses
Table 114. Roche RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Roche RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Roche Recent Developments
Table 117. Sanofi-Aventis Corporation Information
Table 118. Sanofi-Aventis Description and Major Businesses
Table 119. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Sanofi-Aventis RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi-Aventis Recent Developments
Table 122. Abbott Laboratories Corporation Information
Table 123. Abbott Laboratories Description and Major Businesses
Table 124. Abbott Laboratories RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Abbott Laboratories RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Abbott Laboratories Recent Developments
Table 127. Arrowhead Pharmaceuticals Corporation Information
Table 128. Arrowhead Pharmaceuticals Description and Major Businesses
Table 129. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Arrowhead Pharmaceuticals RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Arrowhead Pharmaceuticals Recent Developments
Table 132. Benitec Biopharma Corporation Information
Table 133. Benitec Biopharma Description and Major Businesses
Table 134. Benitec Biopharma RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Benitec Biopharma RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Benitec Biopharma Recent Developments
Table 137. Calimmune Inc Corporation Information
Table 138. Calimmune Inc Description and Major Businesses
Table 139. Calimmune Inc RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Calimmune Inc RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Calimmune Inc Recent Developments
Table 142. Dicerna Corporation Information
Table 143. Dicerna Description and Major Businesses
Table 144. Dicerna RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Dicerna RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Dicerna Recent Developments
Table 147. Gradalis Corporation Information
Table 148. Gradalis Description and Major Businesses
Table 149. Gradalis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Gradalis RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Gradalis Recent Developments
Table 152. Quark Corporation Information
Table 153. Quark Description and Major Businesses
Table 154. Quark RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Quark RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Quark Recent Developments
Table 157. RXi Corporation Information
Table 158. RXi Description and Major Businesses
Table 159. RXi RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. RXi RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. RXi Recent Developments
Table 162. Senesco Corporation Information
Table 163. Senesco Description and Major Businesses
Table 164. Senesco RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 165. Senesco RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Senesco Recent Developments
Table 167. Silence Therapeutics Corporation Information
Table 168. Silence Therapeutics Description and Major Businesses
Table 169. Silence Therapeutics RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 170. Silence Therapeutics RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Silence Therapeutics Recent Developments
Table 172. Silenseed Corporation Information
Table 173. Silenseed Description and Major Businesses
Table 174. Silenseed RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 175. Silenseed RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Silenseed Recent Developments
Table 177. Tekmira Corporation Information
Table 178. Tekmira Description and Major Businesses
Table 179. Tekmira RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 180. Tekmira RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Tekmira Recent Developments
Table 182. Alnylam Pharmaceuticals Corporation Information
Table 183. Alnylam Pharmaceuticals Description and Major Businesses
Table 184. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 185. Alnylam Pharmaceuticals RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Alnylam Pharmaceuticals Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. RNA Drugs Distributors List
Table 190. RNA Drugs Customers List
Table 191. RNA Drugs Market Trends
Table 192. RNA Drugs Market Drivers
Table 193. RNA Drugs Market Challenges
Table 194. RNA Drugs Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Drugs Product Picture
Figure 3. Global RNA Drugs Market Share by Type in 2021 & 2028
Figure 3. siRNA Product Picture
Figure 4. ASO Product Picture
Figure 5. miRNA Product Picture
Figure 6. Nucleic Acid Aptamers Product Picture
Figure 7. Global RNA Drugs Market Share by Application in 2021 & 2028
Figure 8. Cancer
Figure 9. Diabetes
Figure 10. Tuberculosis
Figure 11. Cardiovascular Diseases
Figure 12. Others
Figure 13. RNA Drugs Report Years Considered
Figure 14. Global RNA Drugs Sales 2017-2028 (K Units)
Figure 15. Global RNA Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global RNA Drugs Revenue 2017-2028 (US$ Million)
Figure 17. Global RNA Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global RNA Drugs Sales Market Share by Region (2017-2022)
Figure 19. Global RNA Drugs Sales Market Share by Region (2023-2028)
Figure 20. North America RNA Drugs Sales YoY (2017-2028) & (K Units)
Figure 21. North America RNA Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe RNA Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. Europe RNA Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific RNA Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific RNA Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America RNA Drugs Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America RNA Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa RNA Drugs Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa RNA Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The RNA Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of RNA Drugs in the World: Market Share by RNA Drugs Revenue in 2021
Figure 32. Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global RNA Drugs Sales Market Share by Type (2017-2028)
Figure 34. Global RNA Drugs Revenue Market Share by Type (2017-2028)
Figure 35. Global RNA Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global RNA Drugs Revenue Market Share by Application (2017-2028)
Figure 37. North America RNA Drugs Sales Market Share by Type (2017-2028)
Figure 38. North America RNA Drugs Revenue Market Share by Type (2017-2028)
Figure 39. North America RNA Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America RNA Drugs Revenue Market Share by Application (2017-2028)
Figure 41. North America RNA Drugs Sales Share by Country (2017-2028)
Figure 42. North America RNA Drugs Revenue Share by Country (2017-2028)
Figure 43. U.S. RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Canada RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Europe RNA Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe RNA Drugs Revenue Market Share by Type (2017-2028)
Figure 47. Europe RNA Drugs Sales Market Share by Application (2017-2028)
Figure 48. Europe RNA Drugs Revenue Market Share by Application (2017-2028)
Figure 49. Europe RNA Drugs Sales Share by Country (2017-2028)
Figure 50. Europe RNA Drugs Revenue Share by Country (2017-2028)
Figure 51. Germany RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. France RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Italy RNA Drugs Revenue (2017-2

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group1700122

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

50S Ribosomal Subunit (50S RNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players 50S Ribosomal Subunit (50S RNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Summary 50S Ribosomal Subunit (50S RNA) Drugs in Development by Therapy Areas and Indicat...
30S Ribosomal Subunit (30S RNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players 30S Ribosomal Subunit (30S RNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Summary 30S Ribosomal Subunit (30S RNA) Drugs in Development by Therapy Areas and Indicat...
Human SARS Coronavirus 2 RNA Dependent RNA Polymerase (RdRp or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Human SARS Coronavirus 2 RNA Dependent RNA Polymerase (RdRp or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Summary Human SARS Coronavirus 2 RNA Dependen...
Polymerase Basic Protein 2 (RNA Directed RNA Polymerase Subunit P3 or PB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Polymerase Basic Protein 2 (RNA Directed RNA Polymerase Subunit P3 or PB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Summary Polymerase Basic Protein 2 (RNA Direct...
RNA Directed RNA Polymerase (EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players RNA Directed RNA Polymerase (EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Summary RNA Directed RNA Polymerase (EC 2.7.7.48) Drugs in Development by Thera...
DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Summary DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) Drugs in Deve...
Cyclin Dependent Kinase 8 (Protein Kinase K35 or Mediator Of RNA Polymerase II Transcription Subunit CDK8 or Cell Division Protein Kinase 8 or Mediator Complex Subunit CDK8 or CDK8 or EC 2.7.11.22 or EC 2.7.11.23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Cyclin Dependent Kinase 8 (Protein Kinase K35 or Mediator Of RNA Polymerase II Transcription Subunit CDK8 or Cell Division Protein Kinase 8 or Mediator Complex Subunit CDK8 or CDK8 or EC 2.7.11.22 or EC 2.7.11.23) Drugs in Development by Therapy Area...
23S Ribosomal RNA (23S rRNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players 23S Ribosomal RNA (23S rRNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Summary 23S Ribosomal RNA (23S rRNA) Drugs in Development by Therapy Areas and Indications, ...
16S Ribosomal RNA (16S rRNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players 16S Ribosomal RNA (16S rRNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Summary 16S Ribosomal RNA (16S rRNA) Drugs in Development by Therapy Areas and Indications, ...
Global RNA Drugs Market Research Report 2021 The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *

We're Here To Help You

Request for Sample of this report